|Science Projects||Project Guides||Ask An Expert||Blog||Science Careers||Teachers||Parents||Students|
January 10, 2019
In a new study published in Cell Stem Cell, a team of researchers from Perelman School of Medicine at the University of Pennsylvania, have demonstrated--using fat cells derived from human stem cells -- that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals. Read more
Reading level: College
EurekAlert!, the online, global news service operated by AAAS, the science society
Please Give Us Feedback!